NCM · Medical - Diagnostics & Research

Advanced Biomed Inc. (ADVB) Stock

$5.31 -13.24% NCM: ADVB Healthcare

Valuation

MetricValue
Price$5.31
Market Cap$7.34M
P/E Ratio-29.77
P/B Ratio0.88
P/S Ratio0.00
EPS (TTM)$-0.16
52-Week High$24.23
52-Week Low$3.61
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.71%
ROA-6.36%
ROCE-11.88%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.08
Current Ratio2.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-2.0M$0$-3.0M$0
Net Profit$-2.0M$-4.0M$0$-3.0M$0
EPS$-0.06$-0.13$-0.11$-0.08$-0.09
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$7.0M$5.0M$4.0M$7.0M
Total Liabilities$0$3.0M$3.0M$3.0M$3.0M
Cash$0$5.0M$3.0M$3.0M$3.0M
Borrowings$0$0$0$0$1.0M

Latest News

Top Premarket Gainers MT Newswires · Jul 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$-3.0M$-2.0M$0
Investing Cash Flow$0$-2.0M$0$0$0
Financing Cash Flow$0$0$-1.0M$0$0
Net Cash Flow$0$5.0M$-2.0M$0$0
Free Cash Flow$0$-2.0M$-3.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA-6.84
FCF Yield-7.93%
Quick Ratio7.38
Interest Coverage-9783.79
Return 1Y-67.50%
Return 3Y—
Return 5Y—

Ownership

Insiders Held73.92%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Xtx Topco Ltd1,3632025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APM $0.81 -0.78% -4.42 $5.15M 0.00%
BGLCBioNexus Gene Lab Corp $1.29 +3.20% -1.01 $3.12M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%
GELSGelteq Limited $0.52 -5.03% -2.08 $4.78M 0.00%
MBIOMustang Bio, Inc. $0.40 -4.05% -1.05 $3.03M 0.00%

About Advanced Biomed Inc.

Advanced Biomed Inc. is led by CEO Yi Lu, employs 40 people, headquartered in US, publicly traded since 2025.

Advanced Biomed Inc. (ADVB) stock trades at $5.31 with a market capitalization of $7.34M. The stock is valued at a price-to-earnings (P/E) ratio of -29.77, price-to-book of 0.88, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.61 and $24.23, and currently trades 78.1% below its 52-week high.

On profitability, Advanced Biomed Inc. generates a return on equity (ROE) of -20.71%, return on capital employed of -11.88%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides